Literature DB >> 9101563

Insulin injections promote the growth of aberrant crypt foci in the colon of rats.

D E Corpet1, C Jacquinet, G Peiffer, S Taché.   

Abstract

The main objective of the present study was to test the hypothesis that exogenous insulin would enhance colon carcinogenesis. Thirty-six female Fischer 344 rats were fed ad libitum a low-fat rodent chow and given a single azoxymethane injection (20 mg/kg); one week later, they were randomized into two groups. Control rats were given a subcutaneous saline injection, 5 days/wk, and experimental rats were given Ultralente bovine insulin (20 U/kg). The promoting effect of insulin injections was assessed by the multiplicity (number of crypts) of aberrant crypt foci after 100 days of treatment (72 injections). The rats given insulin ate more and were heavier than controls (215 +/- 11 vs. 182 +/- 7 g, p < 0.001). Insulin injections also increased the amount of abdominal fat, plasma triglycerides, and insulinemia and decreased blood glucose (all p < 0.05). The number of aberrant crypt foci was the same in both groups, but their multiplicity was significantly increased by the insulin injections (2.8 +/- 0.3 vs. 2.5 +/- 0.2 crypt/focus in controls, p = 0.007). In addition, the proportion of sialomucin-producing foci was higher in insulin-injected rats than in controls (p = 0.04). These data show that exogenous insulin can promote colon carcinogenesis in rats and suggest that life-style and diets leading to low blood insulin might protect humans against colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101563      PMCID: PMC2815299          DOI: 10.1080/01635589709514543

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  35 in total

1.  K-ras and p53 mutations in human colorectal aberrant crypt foci.

Authors:  L Losi; L Roncucci; C di Gregorio; M P de Leon; J Benhattar
Journal:  J Pathol       Date:  1996-03       Impact factor: 7.996

2.  Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction.

Authors:  J C Heuson; N Legros
Journal:  Cancer Res       Date:  1972-02       Impact factor: 12.701

3.  Insulin promotion of colon tumors in rats.

Authors:  T T Tran; A Medline; W R Bruce
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-12       Impact factor: 4.254

Review 4.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

Review 5.  Colorectal cancer: the role of dietary fat and caloric restriction.

Authors:  D Kritchevsky
Journal:  Mutat Res       Date:  1993-11       Impact factor: 2.433

6.  Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate.

Authors:  T P Pretlow; M A O'Riordan; G A Somich; S B Amini; T G Pretlow
Journal:  Carcinogenesis       Date:  1992-09       Impact factor: 4.944

Review 7.  Growth kinetics and chemoprevention of aberrant crypts in the rat colon.

Authors:  M J Wargovich; C Harris; C D Chen; C Palmer; V E Steele; G J Kelloff
Journal:  J Cell Biochem Suppl       Date:  1992

Review 8.  Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia.

Authors:  E Shafrir
Journal:  Diabetes Metab       Date:  1996-04       Impact factor: 6.041

Review 9.  Nutrition and breast cancer risk: can an effect via insulin resistance be demonstrated?

Authors:  B A Stoll
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

10.  Mucous secretion in rat colonic mucosa during carcinogenesis induced by dimethylhydrazine. A morphological and histochemical study.

Authors:  M I Filipe
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

View more
  38 in total

1.  Associations between obesity and cancer: the role of fatty acid synthase.

Authors:  Dingzhi Wang; Raymond N Dubois
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

2.  Is diabetes a risk factor for colorectal cancer?

Authors:  Hamed Khalili; Andrew T Chan
Journal:  Dig Dis Sci       Date:  2012-04-25       Impact factor: 3.199

Review 3.  Diabetes mellitus is an independent risk factor for colorectal cancer.

Authors:  Lei Sun; Shiying Yu
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

4.  Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study.

Authors:  Ali A Siddiqui; Stuart J Spechler; Sergio Huerta; Serag Dredar; Bertis B Little; Byron Cryer
Journal:  Dig Dis Sci       Date:  2008-04-12       Impact factor: 3.199

5.  Insulin therapy and colorectal adenomas in patients with diabetes mellitus.

Authors:  Patricia Wong; Mark G Weiner; Wei-Ting Hwang; Yu-Xiao Yang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-09       Impact factor: 4.254

6.  Type 2 diabetes and the risk of colorectal adenomas: Black Women's Health Study.

Authors:  Chiranjeev Dash; Julie R Palmer; Deborah A Boggs; Lynn Rosenberg; Lucile L Adams-Campbell
Journal:  Am J Epidemiol       Date:  2013-10-02       Impact factor: 4.897

7.  Glycemic index, nutrient density, and promotion of aberrant crypt foci in rat colon.

Authors:  D E Corpet; G Peiffer; S Taché
Journal:  Nutr Cancer       Date:  1998       Impact factor: 2.900

8.  Absence of non-alcoholic fatty liver disease in the presence of insulin resistance is a strong predictor for colorectal carcinoma.

Authors:  Sebahat Basyigit; Metin Uzman; Ayse Kefeli; Ferdane Pirincci Sapmaz; Abdullah Ozgür Yeniova; Yasar Nazligul; Zeliha Asiltürk
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  Obesity is associated with an increased prevalence of advanced adenomatous colon polyps in a male veteran population.

Authors:  Ali Siddiqui; Helene N Pena Sahdala; Hector E Nazario; Amar Mahgoub; Mahir Patel; Daisha Cipher; Stuart Spechler
Journal:  Dig Dis Sci       Date:  2009-04-28       Impact factor: 3.199

Review 10.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.